Table 1.

Clinical comparison of patients (including the current one) against series of patients with Merkel cell carcinoma only.

	From references below	Heath et al	Lemos et al	Allen et al
Median age at MCC dx/(m/f)	72.8 (25/12)	69 (114/81)	76 (61%/39%)*	69 (150/101)
Years with CLL before MCC	4.56	4.1% with CLL	n/a	n/a
largest dimension (cm)	2.4	1.8	n/a	1.5 cm
% with metastatic dz at dx	38%	43%	34%	30%
% with local recurrence (time until)	32% (3 mo)	n/a	n/a	8%
Survival	54% dead by 17 mo	n/a	40% survival at 5 years	5 yr DSS 64%

Note: Only patients (n=37) with reported clinical information were included in this table. They are summarized from references 9, 12–27. MCC, Merkel cell carcinoma; CLL, chronic lymphocytic lymphoma; dx, diagnosis; m, male; f, female; dz, disease; DSS, disease specific survival; mo, months;

^* percentage of males and females.